168 related articles for article (PubMed ID: 23505486)
1. Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton.
Atemnkeng VA; Pink M; Schmitz-Spanke S; Wu XJ; Dong LL; Zhao KH; May C; Laufer S; Langer B; Kaiser A
PLoS One; 2013; 8(3):e58318. PubMed ID: 23505486
[TBL] [Abstract][Full Text] [Related]
2. Completing the hypusine pathway in Plasmodium.
Frommholz D; Kusch P; Blavid R; Scheer H; Tu JM; Marcus K; Zhao KH; Atemnkeng V; Marciniak J; Kaiser AE
FEBS J; 2009 Oct; 276(20):5881-91. PubMed ID: 19740108
[TBL] [Abstract][Full Text] [Related]
3. New insights into novel inhibitors against deoxyhypusine hydroxylase from plasmodium falciparum: compounds with an iron chelating potential.
von Koschitzky I; Gerhardt H; Lämmerhofer M; Kohout M; Gehringer M; Laufer S; Pink M; Schmitz-Spanke S; Strube C; Kaiser A
Amino Acids; 2015 Jun; 47(6):1155-66. PubMed ID: 25715757
[TBL] [Abstract][Full Text] [Related]
4. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax.
Njuguna JT; Nassar M; Hoerauf A; Kaiser AE
BMC Microbiol; 2006 Oct; 6():91. PubMed ID: 17042947
[TBL] [Abstract][Full Text] [Related]
7. Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
Kerscher B; Nzukou E; Kaiser A
Amino Acids; 2010 Feb; 38(2):471-7. PubMed ID: 19956997
[TBL] [Abstract][Full Text] [Related]
8. Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy.
von Koschitzky I; Kaiser A
Amino Acids; 2013 Nov; 45(5):1047-53. PubMed ID: 23943044
[TBL] [Abstract][Full Text] [Related]
9. Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties.
Kaiser A; Hammels I; Gottwald A; Nassar M; Zaghloul MS; Motaal BA; Hauber J; Hoerauf A
Bioorg Med Chem; 2007 Sep; 15(18):6200-7. PubMed ID: 17591443
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
11. Deoxyhypusine hydroxylase is a Fe(II)-dependent, HEAT-repeat enzyme. Identification of amino acid residues critical for Fe(II) binding and catalysis [corrected].
Kim YS; Kang KR; Wolff EC; Bell JK; McPhie P; Park MH
J Biol Chem; 2006 May; 281(19):13217-13225. PubMed ID: 16533814
[TBL] [Abstract][Full Text] [Related]
12. A rapid and robust assay for the determination of the amino acid hypusine as a possible biomarker for a high-throughput screening of antimalarials and for the diagnosis and therapy of different diseases.
Kaiser A; Khomutov AR; Simonian A; Agostinelli E
Amino Acids; 2012 May; 42(5):1651-9. PubMed ID: 21360085
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the parasite lactate dehydrogenase gene from Plasmodium vivax Korean isolates.
Shin HI; Kim JY; Lee WJ; Sohn Y; Lee SW; Kang YJ; Lee HW
Malar J; 2013 May; 12():166. PubMed ID: 23688062
[TBL] [Abstract][Full Text] [Related]
14. Translation initiation factor eIF-5A from Plasmodium falciparum.
Molitor IM; Knöbel S; Dang C; Spielmann T; Alléra A; König GM
Mol Biochem Parasitol; 2004 Sep; 137(1):65-74. PubMed ID: 15279952
[TBL] [Abstract][Full Text] [Related]
15. Global occurrence of Plasmodium vivax-like human malaria parasite.
Qari SH; Shi YP; Povoa MM; Alpers MP; Deloron P; Murphy GS; Harjosuwarno S; Lal AA
J Infect Dis; 1993 Dec; 168(6):1485-9. PubMed ID: 8245533
[TBL] [Abstract][Full Text] [Related]
16. Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder.
Ziegler A; Steindl K; Hanner AS; Kar RK; Prouteau C; Boland A; Deleuze JF; Coubes C; Bézieau S; Küry S; Maystadt I; Le Mao M; Lenaers G; Navet B; Faivre L; Tran Mau-Them F; Zanoni P; Chung WK; Rauch A; Bonneau D; Park MH
Am J Hum Genet; 2022 Aug; 109(8):1549-1558. PubMed ID: 35858628
[TBL] [Abstract][Full Text] [Related]
17. Pilot survey of expressed sequence tags (ESTs) from the asexual blood stages of Plasmodium vivax in human patients.
Merino EF; Fernandez-Becerra C; Madeira AM; Machado AL; Durham A; Gruber A; Hall N; del Portillo HA
Malar J; 2003 Jul; 2():21. PubMed ID: 12914668
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium vivax: molecular cloning, expression and characterization of glutathione S-transferase.
Na BK; Kang JM; Kim TS; Sohn WM
Exp Parasitol; 2007 Aug; 116(4):414-8. PubMed ID: 17459379
[TBL] [Abstract][Full Text] [Related]
19. Investigation of an Allosteric Deoxyhypusine Synthase Inhibitor in
Aroonsri A; Wongsombat C; Shaw P; Franke S; Przyborski J; Kaiser A
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458660
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax and Plasmodium knowlesi: cloning, expression and functional analysis of 1-Cys peroxiredoxin.
Hakimi H; Asada M; Angeles JM; Kawai S; Inoue N; Kawazu S
Exp Parasitol; 2013 Jan; 133(1):101-5. PubMed ID: 23178658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
